483
AirScan Inc. d/b/a HemaTechnologiesAirScan Inc. d/b/a HemaTechnologies – FDA 483, Mar 24, 2023
Record Details
An FDA inspection of AirScan Inc. d/b/a HemaTechnologies in Lebanon, NJ, identified nine significant deficiencies in their quality system. The firm failed to adequately establish and implement procedures for critical areas such as complaint handling, rework, corrective and preventive actions, and vendor management. These observations indicate a broad lack of adherence to quality system requirements for their medical devices.
- Person
View Company Profile
ID · f2416853-ed22-440d-a6c6-17b88d2e1b10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.